• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Not Available].

作者信息

Sturm Andreas, Atreya Raja, Bettenworth Dominik, Bokemeyer Bernd, Dignaß Axel, Ehehalt Robert, Germer Christoph, Grunert Philip C, Helwig Ulf, Herrlinger Klaus, Kienle Peter, Kreis Martin E, Kucharzik Torsten, Langhorst Jost, Maaser Christian, Ockenga Johann, Ott Claudia, Siegmund Britta, Zeißig Sebastian, Stallmach Andreas

机构信息

Klinik für Innere Medizin mit Schwerpunkt Gastroenterologie, DRK Kliniken Berlin Westend, Berlin, Deutschland.

Medizinische Klinik 1, Universitätsklinikum Erlangen, Deutschland.

出版信息

Z Gastroenterol. 2022 Mar;60(3):332-418. doi: 10.1055/a-1713-3941. Epub 2022 Mar 9.

DOI:10.1055/a-1713-3941
PMID:35263784
Abstract
摘要

相似文献

1
[Not Available].[无可用内容]。
Z Gastroenterol. 2022 Mar;60(3):332-418. doi: 10.1055/a-1713-3941. Epub 2022 Mar 9.
2
[Not Available].
Z Gastroenterol. 2022 Mar;60(3):295-296. doi: 10.1055/a-1713-4177. Epub 2022 Mar 9.
3
[Not Available].
Z Gastroenterol. 2022 Mar;60(3):e228-e235. doi: 10.1055/a-1713-4138. Epub 2022 Mar 9.
4
[Ulcerative colitis and Crohn disease. Summary of lectures from the workshop of the Czech Society for Gastroenterology and Nutrition on March 3, 1979 in Prague].[溃疡性结肠炎与克罗恩病。1979年3月3日于布拉格举行的捷克胃肠病学与营养学会研讨会讲座摘要]
Cesk Gastroenterol Vyz. 1979 Oct;33(7):446-53.
5
[Wolfgang Schepp MD - Introduction of the conference chairman 2018 of the German Society of Gastroenterology, Digestive and Metabolic Diseases].[沃尔夫冈·谢普医学博士 - 德国胃肠病学、消化与代谢疾病学会2018年会议主席介绍]
Z Gastroenterol. 2018 Aug;56(8):893-894. doi: 10.1055/a-0657-0623. Epub 2018 Aug 13.
6
[Digestive and metabolic diseases].
Munch Med Wochenschr. 1962 Apr 6;104:648-52.
7
[Digestive and metabolic diseases].
Munch Med Wochenschr. 1963 Feb 8;105:311-7.
8
[Digestive and metabolic diseases].
Munch Med Wochenschr. 1959 Sep 4;101:1527-32.
9
[Digestive and metabolic diseases].
Munch Med Wochenschr. 1959 Nov 6;101:2041-5.
10
[Digestive- and metabolic diseases].
Munch Med Wochenschr. 1960 Jun 3;102:1168-73.

引用本文的文献

1
Malignancy and Inflammatory Bowel Disease (IBD): Incidence and Prevalence of Malignancy in Correlation to IBD Therapy and Disease Activity-A Retrospective Cohort Analysis over 5 Years.恶性肿瘤与炎症性肠病（IBD）：与IBD治疗及疾病活动相关的恶性肿瘤发病率和患病率——一项为期5年的回顾性队列分析
Biomedicines. 2025 Jun 6;13(6):1395. doi: 10.3390/biomedicines13061395.
2
Treatment sequences, outcomes, healthcare utilization, and costs in patients with inflammatory bowel diseases requiring advanced treatment-real world comparative effectiveness from German claims data.炎症性肠病患者需要高级治疗的治疗序列、结局、医疗保健利用情况及成本——来自德国索赔数据的真实世界比较有效性
BMC Gastroenterol. 2025 Jun 6;25(1):436. doi: 10.1186/s12876-025-04022-7.
3
[Position paper of the Society for Paediatric Gastroenterology and Nutrition (GPGE) on the off-label use of biologics and signal inhibitors in children and adolescents with IBD that have already been approved for adults].[儿科学胃肠病学与营养学会（GPGE）关于已获批用于成人的生物制剂和信号抑制剂在儿童及青少年炎症性肠病中的超说明书使用的立场文件]
Z Gastroenterol. 2025 Mar;63(3):255-268. doi: 10.1055/a-2474-3104. Epub 2025 Feb 17.
4
The Administrative Prevalence and Pharmacotherapy of Chronic Inflammatory Bowel Diseases, 2012–2020.2012 - 2020年慢性炎症性肠病的行政患病率及药物治疗
Dtsch Arztebl Int. 2024 Dec 13;121(25):847-848. doi: 10.3238/arztebl.m2024.0138.
5
[Application of advanced treatment in chronic inflammatory bowel diseases].[先进治疗方法在慢性炎症性肠病中的应用]
Inn Med (Heidelb). 2025 Jan;66(1):3-14. doi: 10.1007/s00108-024-01833-w. Epub 2025 Jan 2.
6
The Care of Children and Adolescents with Chronic Inflammatory Bowel Disease: A Cluster-Randomized Trial on Improving the Guideline Conformity of Treatment by the Use of the CEDATA-GPGE Patient Registry.慢性炎症性肠病患儿及青少年的护理：一项关于通过使用CEDATA-GPGE患者登记系统提高治疗指南依从性的整群随机试验
Dtsch Arztebl Int. 2024 Sep 20;121(19):627-633. doi: 10.3238/arztebl.m2024.0168.
7
Connected health services: Health professionals' role as seen by parents of a child with inflammatory bowel disease.互联健康服务：炎症性肠病患儿家长眼中的医疗专业人员角色
Digit Health. 2024 Aug 16;10:20552076241271772. doi: 10.1177/20552076241271772. eCollection 2024 Jan-Dec.
8
Predictors of improvement in disease activity in childhood and adolescent Crohn's disease: an analysis of age, localization, initial severity and drug therapy - data from the Saxon Registry for Inflammatory Bowel Disease in Children in Germany (2000-2014).儿童和青少年克罗恩病疾病活动改善的预测因素：年龄、定位、初始严重程度和药物治疗的分析 - 来自德国儿童炎症性肠病萨克森登记处的数据（2000-2014 年）。
Eur J Pediatr. 2024 Oct;183(10):4363-4377. doi: 10.1007/s00431-024-05671-8. Epub 2024 Aug 3.
9
Prospective Evaluation of the Prediction Score for a Mild Course of Crohn's Disease (PreMiCC) in Newly Diagnosed Patients With Crohn's Disease: The PROGNOS Study.克罗恩病轻度病程预测评分（PreMiCC）在新诊断克罗恩病患者中的前瞻性评估：PROGNOS研究
Inflamm Bowel Dis. 2025 Mar 3;31(3):677-685. doi: 10.1093/ibd/izae086.
10
Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies.采用STRIDE方案进行炎症性肠病治疗：客观疾病评估对成功实施达标治疗策略的重要性
Dig Dis Sci. 2024 Mar;69(3):657-659. doi: 10.1007/s10620-023-08221-8. Epub 2024 Jan 13.